Medline (MDLN) Debt to Equity (2024 - 2026)
Medline (MDLN) reported Debt to Equity of $1.12 for Q1 2026, down 4.66% on a QoQ basis from $1.17 in Q4 2025.
Medline (MDLN) has 3 years of Debt to Equity data on file, last reported at $1.12 in Q1 2026.
- Quarterly Debt to Equity changed N/A year-over-year to $1.12 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.12 (changed N/A YoY) and the FY2025 annual result came in at $1.17, up 14.6% from the prior year.
- Debt to Equity slipped to $1.12 in Q1 2026 per MDLN's latest filing, from $1.17 in the prior quarter.
- Across five years, Debt to Equity topped out at $1.17 in Q4 2025 and bottomed at $1.02 in Q4 2024.
- The 3-year median for Debt to Equity is $1.12 (2026), against an average of $1.1.
- Peak annual rise in Debt to Equity reached 14.6% in 2025, while the deepest fall reached 14.6% in 2025.
- Tracing MDLN's Debt to Equity over 3 years: stood at $1.02 in 2024, then rose by 14.6% to $1.17 in 2025, then dropped by 4.66% to $1.12 in 2026.
- Per Business Quant, the three latest MDLN Debt to Equity figures stand at $1.12 (Q1 2026), $1.17 (Q4 2025), and $1.02 (Q4 2024).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Debt/Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 146.28 Bn | 141.88 Bn | 1.83 Bn | - |
| 2 | Becton Dickinson | 41.14 Bn | 40.13 Bn | 2.15 Bn | 0.72 |
| 3 | Medline | 29.16 Bn | 35.00 Bn | 1.84 Bn | 1.12 |
| 4 | Resmed | 27.13 Bn | 25.47 Bn | 890.98 Mn | 0.04 |
| 5 | West Pharmaceutical Services | 22.71 Bn | 22.19 Bn | 296.40 Mn | 0.07 |
| 6 | Solventum | 13.26 Bn | 13.26 Bn | 1.10 Bn | 1.02 |
| 7 | Align Technology | 12.22 Bn | 11.16 Bn | 736.59 Mn | - |
| 8 | Cooper Companies | 11.79 Bn | 11.66 Bn | 695.20 Mn | 0.30 |
| 9 | Baxter International | 9.47 Bn | 7.42 Bn | 891.00 Mn | 1.57 |
| 10 | Aptargroup | 7.19 Bn | 6.99 Bn | 351.91 Mn | 0.45 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 28, 2026 | 1.12 |
| Dec 31, 2025 | 1.17 |
| Dec 31, 2024 | 1.02 |